Research Article: Emergence of SARS-CoV- with Dual-Drug Resistant Mutations During a Long-Term Infection in a Kidney Transplant Recipient
Introduction:
Treatment methods for COVID- have been established since the pandemic was first described. Current treatments are effective in many patients; however, immunocompromised patients require long-term treatment, and emerging resistant variants occur more frequently. Resistant variants against sotrovimab, a therapeutic monoclonal antibody, have been reported during its initial administration. – Major escape amino acid mutations from sotrovimab occur at residues and of the spike protein in immunosuppressed patients, such…
Read more